Abstract：
Aneurysmal subarachnoid hemorrhage can be a devastating disease, with an in-hospital mortality rate of up to 20%. The American Heart Association/American Stroke Association 2023 Aneurysmal Subarachnoid Hemorrhage Guidelines provide a comprehensive update to the 2012 Guidelines based on a systematic review of the intervening evidence. The guidelines are broad in scope, covering prehospital care, aneurysm treatment modality, medical complications, detection and treatment of delayed cerebral ischemia, and recovery. Here, we comment on salient aspects of aneurysmal subarachnoid hemorrhage care, compare these guidelines with the 2023 Neurocritical Care aneurysmal subarachnoid hemorrhage guidelines, and review relevant updates.
摘要：
动脉瘤性蛛网膜下腔出血可能是一种毁灭性的疾病，住院死亡率高达20%。美国心脏协会/美国中风协会2023年动脉瘤性蛛网膜下腔出血指南基于对干预证据的系统评价，对2012年指南进行了全面更新。准则范围广,涵盖院前护理，动脉瘤治疗模式，医疗并发症,迟发性脑缺血的检测和治疗，和恢复。这里,我们评论了动脉瘤性蛛网膜下腔出血护理的突出方面，将这些指南与2023年神经重症监护动脉瘤性蛛网膜下腔出血指南进行比较，并审查相关更新。
